Frankfurt - Delayed Quote EUR
Soleno Therapeutics, Inc. (6XC.F)
64.85
+0.80
+(1.25%)
At close: May 9 at 3:29:01 PM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-69,096
-69,096
-24,940
-20,781
-27,770
Investing Cash Flow
-225,682
-225,682
0
-13
-22
Financing Cash Flow
213,025
213,025
180,019
14,092
-128
End Cash Position
87,928
87,928
169,681
14,602
21,304
Capital Expenditure
-218
-218
--
-13
-22
Issuance of Capital Stock
148,955
148,955
137,857
14,108
0
Issuance of Debt
49,888
49,888
0
0
--
Repayment of Debt
--
--
--
0
-8
Free Cash Flow
-69,314
-69,314
-24,940
-20,794
-27,792
12/31/2021 - 8/28/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
328.SG MeiraGTx Holdings PLC
4.8400
+0.83%
BSFAF BSF Enterprise Plc
0.0584
0.00%
CSJA.F CSL Limited
66.50
0.00%
XUPB.F Genfit S.A.
3.7800
-0.53%
688428.SS InnoCare Pharma Limited
20.56
+0.54%
25I.SG ImmuPharma PLC
0.0295
0.00%
ABRT.CN Albert Labs International Corp.
0.0050
0.00%
SCP.F Scancell Holdings plc
0.0825
-13.16%
22Z.SG Zealand Pharma A/S
56.18
-6.30%
688266.SS Suzhou Zelgen Biopharmaceuticals Co.,Ltd.
99.49
+4.18%